Company intelligence / Profile preview

NanoTemper Technologies

Munich, Bavaria, Germanynanotempertech.com ↗

Ownership: Private
Development stage: Commercial

Overview

NanoTemper Technologies develops and sells advanced biophysical instruments used globally by pharmaceutical companies, biotech firms, and academic researchers to accelerate drug discovery and development. Their technologies enable precise measurement of molecular interactions and protein stability. No clinical results as they do not develop drugs.

Modalities: Device (biophysical instrumentation for protein/biomolecule analysis)
Industry: Drug Discovery Services

Partnerships

Collaborates with global distributors and scientific partners

Beyond the preview

Go deeper on NanoTemper Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoTemper Technologies.

Explore the full profile